Trial Profile
Clinical Trials Insight: 700045769
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Jun 2009
Price :
$35
*
At a glance
- Drugs AT 101 (Primary) ; Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Ascenta Therapeutics
- 01 Jun 2009 New trial record.